- Current Research (2022-2024)
- Precision medicine: study of deregulated functional networks in neoplasms by integrated proteomic and metabolomic analysis
- Use of “omic” approaches for the study of the pathogenetic mechanisms underlying neurodegenerative and neurodevelopmental diseases, to search biomarkers and molecular targets useful in the prognosis and to develop drug therapies
- Rational design, synthesis and characterization of molecules of therapeutic interest and their transport through nanovectors. Reposition of existing drugs through computational simulations; evaluations of efficacy and toxicity
- Development and implementation of algorithms and innovative software to support oncology research
- Finalized Search
- An innovative approach to NSCLC lung cancer therapy. Preclinical assays with Fraisinib: a heterocyclophane with low toxicity and high antitumor activity in vivo (5 × 1000 2018-2019 San Martino Polyclinic Hospital).
- Breast cancer: study of tumor heterogeneity through genomic analysis, proteomics and pre-clinical models (5 × 1000 2015 San Martino Polyclinic Hospital)
- Design, synthesis and evaluation of new STAT3 inhibitors (Compagnia di San Paolo Foundation – Turin)
- EOSC-Life: Providing an open collaborative space for digital biology in Europe (European Union, H2020, 2019-2023
- IS_MIRRI21: Implementation and Sustainability of Microbial Resource Research Infrastructure for 21st Century (European Union, H2020, 2020-2023
- BY-COVID: BeYond-COVID (European Union, Horizon Europe, 2021-2024)
- MicroBioDiverSar: Microbial Biodiversity of Sardinia (MIPAAF, 2018-2020)
- Coordination activities
- COST Action STRATAGEM – New diagnostic and therapeutic tools against multidrug resistant tumours
- COST Action “ENOVA – Vaccine Adjuvants“
- COST Action “Cancer nanomedicine – from the bench to the bedside“
- ESFRI Research Infrastructure MIRRI (Microbial Resource Research Infrastructure)
- Joint Research Unit MIRRI-IT (Italian National Node of MIRRI).
Home » Projects
